A comparative study of the antinociceptive action of xenon and nitrous oxide in rats

Anesthesia and Analgesia

Volumn 85, Issue 4, 1997, Pages 931-936

  Ohara, Akitoshi ^a   Mashimo, Takashi ^a   Zhang, Ping ^a   Inagaki, Yoshimi ^a   Shibuta, Satoshi ^a   Yoshiya, Ikuto ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; N [2 (1,3,4,6,7,12B HEXAHYDRO 2' OXOSPIRO[2H BENZOFURO[2,3 A]QUINOLIZINE 2,4' IMIDAZOLIDIN] 3' YL)ETHYL]METHANESULFONAMIDE; NALOXONE; NITROUS OXIDE; XENON; YOHIMBINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BLOOD BRAIN BARRIER; DRUG ACTIVITY; DRUG MECHANISM; DRUG SCREENING; INHALATIONAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

ANALGESICS, NON-NARCOTIC; ANIMALS; MALE; NALOXONE; NITROUS OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; XENON; YOHIMBINE;

EID: 0030882721     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199710000-00039     Document Type: Article

References (47)

1. Amess JAL, Burman JF, Ress GM, et al. Megaloblastic haemopoiesis in patients receiving nitrous oxide. Lancet 1978;2: 339-42.
2. Lane GA, Nahrwold ML, Tait AR, et al. Anesthetics as teratogens: nitrous oxide is fetotoxic, xenon is not. Science 1980; 210:899-901.
3. Fujinaga M, Baden JF. Methionine prevents nitrous oxideinduced teratogenicity in rat embryos grown in culture. Anesthesiology 1994;81:184-9.
4. Dyck PJ, Grina LA, Lambert EH, et al. Nitrous oxide neurotoxicity studies in man and rat. Anesthesiology 1980;53:205-9.
5. Cullen SC, Gross EG. The anesthetic properties of xenon in animals and human beings, with additional observations on krypton. Science 1951;113:580-2.
6. Pittinger CB, Moyers J, Cullen SC, et al. Clinicopathologic studies associated with xenon anesthesia. Anesthesiology 1953;14: 10-7.
7. Morris LE, Knott JR, Pittinger CB. Electro-encephalographic and blood gas observations in human surgical patients during xenon anesthesia. Anesthesiology 1955;16:312-9.
8. Cullen SC, Eger EI II, Cullen BF, Gregory P. Observations on the anesthetic effect of the combination of xenon and halothane. Anesthesiology 1967;28:243-4.
9. Eger EI II, Larson CP Jr. Anaesthetic solubility in blood and tissues: values and significance. Br J Anaesth 1964;36:140-9.
10. Lachmann B, Armbruster S, Schairer W, et al. Safety and efficacy of xenon in routine use as an inhalational anaesthetic. Lancet 1990;335:1413-5.
11. Luttropp HH, Rydgren G, Thomasson R, Werner O. A minimal-flow system for xenon anesthesia. Anesthesiology 1991;75: 896-902.
12. Dundee JW, Moore J. Alterations in response to somatic pain associated with anaesthesia. IV. The effects of subanaesthetic concentrations of inhalation agents. Br J Anaesth 1960;32:453-9.
13. Robson JG, Davenport HT, Sugiyama R. Differentiation of two types of pain by anesthetics. Anesthesiology 1965;26:31-4.
14. Lachmann B, Trouwborst A, Schairer W, et al. Xenon anesthesia and its analgesic effects. In: Abstracts of the 9th World Congress on Anaesthetics. Vol 1. Washington, DC: World Congress on Anaesthetics, 1988:A0079.
15. Tomi K, Mashimo T, Tashiro C, et al. Alterations in pain threshold and psychomotor response associated with subanaesthetic concentrations of inhalation anaesthetics in humans. Br J Anaesth 1993;70:684-6.
16. Yagi M, Mashimo T, Kawaguchi T, Yoshiya I. Analgesic and hypnotic effects of subanaesthetic concentration of xenon in human volunteers: a comparison with nitrous oxide. Br J Anaesth 1995;74:670-3.
17. Berkowitz BA, Ngai SH, Finck AD. Nitrous oxide "analgesia": resemblance to opiate action. Science 1976;194:967-8.
18. Berkowitz BA, Finck AD, Ngai SH. Nitrous oxide analgesia: reversal by naloxone and development of tolerance. J Pharmacol Exp Ther 1977;203:539-47.
19. Chapman CR, Benedetti C. Nitrous oxide effects on cerebral evoked potential to pain: partial reversal with a narcotic antagonist. Anesthesiology 1979;51:135-8.
20. Yang JC, Clark WC, Ngai SH. Antagonism of nitrous oxide analgesia by naloxone in man. Anesthesiology 1980;52:414-7.
21. Zuniga J, Joseph S, Knigge K. Nitrous oxide analgesia: partial antagonism by naloxone and total reversal after periaqueductal gray lesions in the rat. Eur J Pharmacol 1987;142:51-60.
22. Moody EJ, Mattson M, Newman AH, et al. Stereospecific reversal of nitrous oxide analgesia by naloxone. Life Sci 1989;44: 703-9.
23. Shingu K, Osawa M, Omatsu Y, et al. Naloxone does not antagonize the anesthetic-induced depression of nociceptor-driven spinal cord response in spinal cats. Acta Anaesthesiol Scand 1981;25:526-32.
24. Levine JD, Gordon NC, Fields HL. Naloxone fails to antagonize nitrous oxide analgesia for clinical pain. Pain 1982;13:165-70.
25. Willer J-C, Bergeret S, Gaudy J-H, Dauthier C. Failure of naloxone to reverse the nitrous oxide-induced depression of a brain stem reflex: an electrophysiologic and double-blind study in humans. Anesthesiology 1985;63:467-72.
26. Berkowitz BA, Finck AD, Hynes MD, Ngai SH. Tolerance to nitrous oxide analgesia in rats and mice. Anesthesiology 1979; 51:309-12.
27. Rupreht J, Ukponmwan OE, Dworacek B, et al. Enkephainase inhibition prevented tolerance to nitrous oxide analgesia in rat. Acta Anaesthesiol Scand 1984;28:617-20.
28. Rupreht J, Dworacek B, Bonke B, et al. Tolerance to nitrous oxide in volunteers. Acta Anaesthesiol Scand 1985;29:635-8.
29. Ramsay DS, Brown AC, Woods SC. Acute tolerance to nitrous oxide in humans. Pain 1992;51:367-73.
30. Ngai SH, Finck AD. Prolonged exposure to nitrous oxide decreases opiate receptor density in rat brainstem. Anesthesiology 1982;57:26-30.
31. Shingu K, Osawa M, Fukuda K, Mori K. Acute tolerance to the analgesic action of nitrous oxide does not develop in rats. Anesthesiology 1995;62:502-4.
32. Mori K, Winters WD. Neural background of sleep and anesthesia. Int Anesthesiol Clin 1975;13:67-108.
33. Stevens JE, Oshima E, Mori K. Effects of nitrous oxide on the epileptogenic property of enflurane in cats. Br J Anaesth 1983; 55:145-54.
34. Curtis AL, Marwah J. Evidence for alpha adrenoceptor modulation of the nociceptive jaw-opening reflex in rats and rabbits. J Pharmacol Exp Ther 1986;238:576-9.
35. Clineschmidt BV, Pettibone DJ, Lotti VJ, et al. A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066. J Pharmacol Exp Ther 1987;245:32-40.
36. Guo T-Z, Poree L, Golden W, et al. Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal α2-adrenergic receptors in the rat. Anesthesiology 1996;85: 846-52.
37. Fleetwood-Walker SM, Mitchell R, Hope PJ, et al. An α2 receptor mediates the selective inhibition by noradrenaline of nociceptive responses of identified dorsal horn neurones. Brain Res 1985;334:243-54.
38. Jones SL, Gebhart GF. Characterization of coeruleospinal inhibition of the nociceptive tail-flick reflex in the rat: mediation by spinal α2-adrenoceptors. Brain Res 1986;364:315-30.
39. Pertovaara A, Kauppila T, Jyväsjärvi E, Kalso E. Involvement of supraspinal and spinal segmental alpha-2-adrenergic mechanisms in the medetomidine-induced antinociception. Neuroscience 1991;44:705-14.
40. Unnerstall JR, Kopajtic TA, Kuhar MJ. Distribution of α2-agonist binding site in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res Rev 1984;7:69-101.
41. Nicholas AP, Pieribone V, Hökfelt T. Distribution of mRNAs for alpha-2-adrenergic receptor subtypes in rat brain: an in situ hybridization study. J Comp Neurol 1993;328:575-94.
42. Scheinin M, Lomasney JW, Hayden-Hixon D, et al. Distribution of α2-adrenergic receptor subtype gene expression in rat brain. Mol Brain Res 1994;21:133-49.
43. Yaksh TL, Howe JR. Opiate receptors and their definition by antagonists. Anesthesiology 1981;56:246-8.
44. Aghajanian G. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature 1978;276:186-8.
45. Gold MS, Pottash AC. The neurobiological implications of clonidine HCl. Ann N Y Acad Sci 1981;362:191-202.
46. Post C, Archer T, Minor BG. Evidence for crosstolerance to the analgesic effects between morphine and selective α2-adrenoceptor agonists. J Neural Transm 1988;72:1-9.
47. Flacke JW, Flacke WE, Bloor BC, Olewine S. Effects of fentanyl, naloxone, and clonidine on hemodynamics and plasma catecholamine levels in dogs. Anesth Analg 1983;62:305-13.